Bringing new medicines to women with epithelial ovarian cancer: what is the unmet medical need?

por Herzog, Thomas J., Monk, Bradley J.
Publicado 2017

Ovarian Cancer: Current Treatment and Patient Management

por Monk, Bradley J., Anastasia, Paula J.
Publicado 2016

Response to “surgical management of cervical cancer by laparoscopy or laparotomy”

por Leath, Charles A., Monk, Bradley J.
Publicado 2018

Letter to the editor, Reply to: Lee and Matulonis: Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?

por Monk, Bradley J., Mayadev, Jyoti, Nunes, Ana T.
Publicado 2019

Therapeutic options for treatment of human papillomavirus-associated cancers - novel immunologic vaccines: ADXS11–001

por Miles, Brett, Safran, Howard P., Monk, Bradley J.
Publicado 2017

Biosimilars: Extrapolating the evidence. A roundtable discussion

por Monk, Bradley J., Coleman, Morton, Lammers, Philip, Somlo, George
Publicado 2015

Mechanistic insights into ADXS11-001 human papillomavirus-associated cancer immunotherapy

por Miles, Brett A., Monk, Bradley J., Safran, Howard P.
Publicado 2017

Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey

por Monk, Bradley J., Lammers, Philip E., Cartwright, Thomas, Jacobs, Ira
Publicado 2017

Updates on drug discovery in ovarian cancer

por Gibson, Steven J, Tewari, Krishnansu S, Monk, Bradley J, Chase, Dana M
Publicado 2014

Gynecologic Oncology Research and Practice: a new journal to meet the needs of a growing field

por Coleman, Robert L, Herzog, Thomas J, Monk, Bradley J, Dooner, Philip
Publicado 2014

Will bevacizumab biosimilars impact the value of systemic therapy in gynecologic cancers?

por Monk, Bradley J., Huh, Warner K., Rosenberg, Julie Ann, Jacobs, Ira
Publicado 2017

CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III,...

por Mayadev, Jyoti, Nunes, Ana T, Li, Mary, Marcovitz, Michelle, Lanasa, Mark C, Monk, Bradley J
Publicado 2020

Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease

por Arend, Rebecca C., Jackson-Fisher, Amy, Jacobs, Ira A., Chou, Jeffrey, Monk, Bradley J.
Publicado 2021

Evolving treatment paradigms in metastatic or recurrent low-grade endometrial cancer: When is hormonal-based therapy the preferred option?

por Mahdi, Haider, Ray-Coquard, Isabelle, Lorusso, Domenica, Mirza, Mansoor Raza, Monk, Bradley J, Slomovitz, Brian
Publicado 2023

Protein profiling of ovarian cancers by immunohistochemistry to identify potential target pathways

por Foss, Cassandra D, Dalton, Heather J, Monk, Bradley J, Chase, Dana M, Farley, John H
Publicado 2014

Safety and efficacy of salvage nano-particle albumin bound paclitaxel in recurrent cervical cancer: a feasibility study

por Minion, Lindsey E., Chase, Dana M., Farley, John H., Willmott, Lyndsay J., Monk, Bradley J.
Publicado 2016

Identification of Endometrial Cancer-Specific microRNA Biomarkers in Endometrial Fluid

por Yang, Jianing, Barkley, Joel E., Bhattarai, Bikash, Firouzi, Kameron, Monk, Bradley J., Coonrod, Dean V., Zenhausern, Frederic
Publicado 2023

Longitudinal Changes in Sleep: Associations with Shifts in Circulating Cytokines and Emotional Distress in a Cancer Survivor Population

por Tucker, Jo A., Osann, Kathryn, Hsieh, Susie, Wahi, Aditi, Monk, Bradley J., Wenzel, Lari, Nelson, Edward L.
Publicado 2021

Integration of immunotherapy into treatment of cervical cancer: Recent data and ongoing trials

por Monk, Bradley J., Enomoto, Takayuki, Kast, W. Martin, McCormack, Mary, Tan, David S.P., Wu, Xiaohua, González-Martín, Antonio
Publicado 2022

Left Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or Both

por Bonaca, Marc P, Moslehi, Javid J, Ledermann, Jonathan A, Michelon, Elisabete, Wei, Caimiao, Moran, Michael, Monk, Bradley J, Pujade-Lauraine, Eric
Publicado 2023